ERBB2 and breast cancer: To the best of our knowledge, there is not published data on human trials on BC to date, although several initiatives can be found registered in the Clinical Trials.gov repository including multiple trials evaluating the intravenous infusion of ex vivo expanded, autologous NK cells and also the administration of NK cells incorporating HER2- and MUC1-CAR constructs (Table 1).